Drugs / AKF-1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01561521 Comparator | Mar → Apr 2012 | conjunctivitis | Akorn, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AKF-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01561521 ↗ |